Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
bavdegalutamide (ARV-110)
i
Other names:
ARV-110
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(6)
News
Trials
Company:
Arvinas
Drug class:
Androgen receptor degrader
Related drugs:
‹
AC0176 (1)
ONCT-534 (1)
EPI-8207 (0)
HRS-5041 (0)
ARV-766 (0)
AC0176 (1)
ONCT-534 (1)
EPI-8207 (0)
HRS-5041 (0)
ARV-766 (0)
›
Associations
(6)
News
Trials
VERI cancer hierarchy
Reset Filters
AR T878S + AR H875Y
Prostate Cancer
AR T878S + AR H875Y
Prostate Cancer
ARV-110
Sensitive: C3 – Early Trials
ARV-110
Sensitive
:
C3
ARV-110
Sensitive: C3 – Early Trials
ARV-110
Sensitive
:
C3
AR T878A + AR H875Y
Prostate Cancer
AR T878A + AR H875Y
Prostate Cancer
ARV-110
Sensitive: C3 – Early Trials
ARV-110
Sensitive
:
C3
ARV-110
Sensitive: C3 – Early Trials
ARV-110
Sensitive
:
C3
AR H875Y
Prostate Cancer
AR H875Y
Prostate Cancer
ARV-110
Sensitive: C3 – Early Trials
ARV-110
Sensitive
:
C3
ARV-110
Sensitive: C3 – Early Trials
ARV-110
Sensitive
:
C3
AR T878S
Prostate Cancer
AR T878S
Prostate Cancer
ARV-110
Sensitive: C3 – Early Trials
ARV-110
Sensitive
:
C3
ARV-110
Sensitive: C3 – Early Trials
ARV-110
Sensitive
:
C3
AR T878A
Prostate Cancer
AR T878A
Prostate Cancer
ARV-110
Sensitive: C3 – Early Trials
ARV-110
Sensitive
:
C3
ARV-110
Sensitive: C3 – Early Trials
ARV-110
Sensitive
:
C3
AR mutation
Prostate Cancer
AR mutation
Prostate Cancer
ARV-110
Sensitive: C3 – Early Trials
ARV-110
Sensitive
:
C3
ARV-110
Sensitive: C3 – Early Trials
ARV-110
Sensitive
:
C3
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login